Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
March 12, 2014 MED F 657 $26.48 $17,397 1,865 Direct -26.05% Disposed -55.7% (price as of 2026-10-02)
Feb. 5, 2014 MED A 2,000 · · 4,000 Direct +100.00% Acquired (price as of 2026-10-02)
Feb. 5, 2014 MED A 1,875 · · 2,522 Direct +289.80% Acquired (price as of 2026-10-02)
May 23, 2013 MED A 647 $28.32 $18,323 647 Direct · Acquired -58.6% (price as of 2026-10-02)
Feb. 19, 2013 MED A 2,000 · · 2,000 Direct · Acquired (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Feb. 5, 2014 MED Stock Options Common Stock (2,000) $26.52 Feb. 5, 2024 2,000 Acquired
Feb. 19, 2013 MED Stock Options Common Stock (2,000) $24.26 Feb. 19, 2023 2,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
May 28, 2013 MED Common Shares 647 Direct